News

The truth about time management for farm families

Balancing work and home life is a common struggle for many, but farm families face unique challenges that can make time management particularly difficult.
General Results

Report a Concern

We welcome your feedback. Please click on one of the links below to share your experience: Patient Feedback ALERT Links Information on reporting a concern Due process and resident complaint policy
Profiles

Nuri Ozden, MD

Internal Medicine
Profiles

Behzad Elahi, MD, PhD

Neuroscience Institute
Trial
Surgery

IMPROVE-AD

Active recruiting

Improving Outcomes in Vascular Disease – Aortic Dissection

Trial
Surgery

LeAAPS

Active not recruiting

Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction

Trial
Obstetrics & Gynecology

Collection and Banking of Blood Samples for the Study of Gynecological Diseases

Active recruiting

AOA DX is developing a blood test to detect ovarian cancer (biomarker).  The purpose of this study is to collect and store donated blood samples and associated medical data from participating subjects to help develop the ovarian cancer test.

Trial
Simmons Cancer Institute

A Phase 1b/2 Dose-Escalation and Cohort-Expansion Study to Determine the Safety and Efficacy of BGB-11417as Monotherapy, in Combination With Dexamethasone and Carfilzomib/Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma and t(11;14)

Active recruiting

The purpose of the study is to test BGB-11417 (alone, with dexamethasone, and with carfilzomib/dexamethasone in patients with relapsed/refractory multiple myeloma who test positive for t(11;14). .

Trial
Simmons Cancer Institute

EMBER-4: A Randomized, Open-Label, Phase 3 Study of Adjuvant Imlunestrant vs Standard Adjuvant Endocrine Therapy in Patients Who Have Previously Received 2 to 5 Years of Adjuvant Endocrine Therapy for ER+, HER2- Early Breast Cancer With an Increased Risk

Active recruiting

The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-).

Trial
Simmons Cancer Institute

A Phase II Open-Label Study of Sacituzumab Govitecan in Unresectable Locally Advanced/Metastatic Urothelial Cancer

Active not recruiting

The objective of this study is to evaluate the efficacy and safety of sacituzumab govitecan-hziy monotherapy and with novel combinations in participants with metastatic urothelial cancer (mUC).

Subscribe to